Literature DB >> 17602576

The ester group: how hydrofluoroalkane-philic is it?

Robson P S Peguin1, Libo Wu, Sandro R P da Rocha.   

Abstract

Pressurized metered-dose inhalers (pMDIs) have been recognized as potential devices for the delivery of systemically acting drugs, including biomolecules, to and through the lungs. Therefore, the development of novel excipients capable of imparting stability to suspension formulations in hydrofluoroalkane (HFA) propellants is of great relevance because many of the drugs of interest are poorly soluble in HFAs. In this work, we use ab initio calculations and chemical force microscopy (CFM) to determine the HFA-philicity of the biodegradable and biocompatible ester moiety quantitatively. The complementary information obtained from the binding energy calculations and adhesion force measurements are used to gain microscopic insight into the relationship between the chemistry of the moiety of interest and its solvation in HFA. A lactide (LA)-based copolymer surfactant was synthesized and characterized, and its ability to stabilize a dispersion of micronized budesonide in HFA227 was demonstrated. These results corroborate the ab initio calculations and CFM and show that the LA-based moiety is a suitable candidate for enhancing the stability of dispersions in HFA-based pMDIs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17602576     DOI: 10.1021/la700996x

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  2 in total

1.  Core-shell particles for the dispersion of small polar drugs and biomolecules in hydrofluoroalkane propellants.

Authors:  Libo Wu; Balaji Bharatwaj; Jayanth Panyam; Sandro R P da Rocha
Journal:  Pharm Res       Date:  2007-10-17       Impact factor: 4.200

2.  Poly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epithelium.

Authors:  Denise S Conti; Daniel Brewer; Jordan Grashik; Sumant Avasarala; Sandro R P da Rocha
Journal:  Mol Pharm       Date:  2014-05-08       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.